Skip to main content
. 2021 Apr 15;2021(4):CD013346. doi: 10.1002/14651858.CD013346.pub2

Tan 2014.

Study characteristics
Patient Sampling A multi‐stage, case‐control study was designed to identify a serum miRNA profile as a surrogate marker for HCC. A total of 261 HCC patients, 233 patients with cirrhosis and 173 healthy controls were enrolled in our study. Validation set (cohort of interest) included 103 HCC patients, 78 cirrhosis patients and 60 healthy controls serum samples (from The Third Hospital of Zhenjiang Affiliated Jiangsu University).
Age range: 32‐63. Males 67%
Patient characteristics and setting  
Index tests AFP: cut‐off values not predefined or mentioned
Target condition and reference standard(s) HCC: the diagnosis of HCC and cirrhosis was histopathologically confirmed.
Flow and timing No information on interval between index test and reference standard
Comparative  
Notes "Competing Interests: the authors have declared that no competing interests exist."
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? No    
Was a case‐control design avoided? No    
Did the study avoid inappropriate exclusions? Unclear    
Could the selection of patients have introduced bias?   High risk  
Are there concerns that the included patients and setting do not match the review question?     High
DOMAIN 2: Index Test (AFP)
Were the index test results interpreted without knowledge of the results of the reference standard? No    
If a threshold was used, was it pre‐specified? No    
Could the conduct or interpretation of the index test have introduced bias?   High risk  
Are there concerns that the index test, its conduct, or interpretation differ from the review question?     High
DOMAIN 2: Index Test (US+AFP)
DOMAIN 2: Index Test (US)
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? Yes    
Were the reference standard results interpreted without knowledge of the results of the index tests? Yes    
Could the reference standard, its conduct, or its interpretation have introduced bias?   Low risk  
Are there concerns that the target condition as defined by the reference standard does not match the question?     Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference standard? Unclear    
Did all patients receive the same reference standard? Yes    
Were all patients included in the analysis? Yes    
Could the patient flow have introduced bias?   Unclear risk